Skip to main content
SpringerLink
Log in

Biochemical and physiological aspects of protein C

  • III. Proteins Inhibiting Coagulation and Fibrinolysis
  • Published:
Ricerca in clinica e in laboratorio

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Amphlett G. W., Kisiel W., Castellino F. J.: Interaction of calcium with bovine plasma protein C.—Biochemistry20, 2156, 1981.

    Article  PubMed  CAS  Google Scholar 

  2. Awbrey B. J., Hoak J. C., Owen W. G.: Binding of human thrombin to cultured human endothelial cells.—J. biol. Chem.254, 4092, 1979.

    PubMed  CAS  Google Scholar 

  3. Bauer P. I., Machovich R., Aranyi P., Buki K. G., Csonka E., Horvath I.: Mechanism of thrombin binding to endothelial cells.—Blood61, 368, 1983.

    PubMed  CAS  Google Scholar 

  4. Bertina R. M., Broekmans A. W., Van der Linden I. K., Mertens K.: Protein C deficiency in a Dutch family with thrombotic disease.—Thrombos. Haemost.48, 1, 1982.

    CAS  Google Scholar 

  5. Broekmans A. W., Veltkamp J. J., Bertina R. M.: Congenital protein C deficiency and venous thromboembolism. A study of three Dutch families.—New Engl. J. Med.309, 340, 1983.

    PubMed  CAS  Google Scholar 

  6. Busch C., Cancilla P., DeBault L., Goldsmith J., Owen W.: Use of endothelium cultured on microcarriers as a model for the microcirculation.—Lab. Invest.47, 498 1982.

    PubMed  CAS  Google Scholar 

  7. Comp P. C., Esmon C. T.: Generation of fibrinolytic activity by infusion of activated protein C into dogs.—J. clin. Invest.68, 1221, 1981.

    Article  PubMed  CAS  Google Scholar 

  8. Comp P. C., Jacocks R. M., Ferrell G. L., Esmon C. T.: Activation of protein Cin vivo. J. clin. Invest.70, 127, 1982.

    Article  PubMed  CAS  Google Scholar 

  9. Comp P. C., Nixon R. R., Esmon C. T.: Determination of functional levels of protein C, an antithrombotic protein, using a thrombin-thrombomodulin complex.—Blood63, 15, 1984.

    PubMed  CAS  Google Scholar 

  10. Esmon C. T.: Protein C: biochemistry, physiology, and clinical implications.—Blood62, 1155, 1983.

    PubMed  CAS  Google Scholar 

  11. Esmon C. T., Esmon N. L., Harris K. W.: Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalyzed fibrin formation and factor V activation.—J. biol. Chem.257, 7944, 1982.

    PubMed  CAS  Google Scholar 

  12. Esmon C. T., Harris K. W., Esmon N. L., Nixon R. N., DeBault L. E.: The roles of cellular receptors in the activation of protein C and the expression of activated protein C anticoagulant activity.—Thrombos. Haemost.50, 1327, 1983. (Abstract).

    Google Scholar 

  13. Esmon C. T., Owen W. G.: Identification of an endothelial cell cofactor for thrombin catalyzed activation of protein C.—Proc. nat. Acad. Sci. (Wash.)78, 2249, 1981.

    Article  CAS  Google Scholar 

  14. Esmon C. T., Stenflo J., Suttie J. W., Jackson C. M.: A new vitamin K-dependent protein. A phospholipid-binding zymogen of a serine esterase.—J. biol. Chem.251, 3052, 1976.

    PubMed  CAS  Google Scholar 

  15. Esmon N. L., Carroll R. C., Esmon C. T.: Thrombomodulin blocks the ability of thrombin to activate platelets.—J. biol. Chem.258, 12238, 1983.

    PubMed  CAS  Google Scholar 

  16. Esmon N. L., DeBault L. E., Esmon C. T.: Proteolytic formation and properties of γ-carboxyglutamic acid-domainless protein C.—J. biol. Chem.258, 5548, 1983.

    PubMed  CAS  Google Scholar 

  17. Esmon N. L., Owen W. G., Esmon C. T.: Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C.—J. biol. Chem.257, 859, 1982.

    PubMed  CAS  Google Scholar 

  18. Filip D. J., Eckstein J. D., Veltkamp J. J.: Hereditary antithrombin III deficiency and thromboembolic disease.—Amer. J. Hematol.2, 343, 1976.

    Article  Google Scholar 

  19. Grifein J. H., Evatt B., Zimmerman T. S., Kleiss A. J., Wideman C.: Dificiency of protein C in congenital thrombotic disease.—J. clin. Invest.68, 1370, 1981.

    Article  Google Scholar 

  20. Grifein J. H., Mosher D. R., Zimmerman T. S., Kleiss A. J.: Protein C, an antithrombotic protein, is reduced in hospitalized patients with intravascular coagulation.—Blood60, 261, 1982.

    Google Scholar 

  21. Jackson C. M., Nemerson Y.: Blood coagulation.—Ann. Rev. Biochem.49, 765, 1980.

    Article  PubMed  CAS  Google Scholar 

  22. Kisiel W.: Human plasma protein C: isolation, characterization and mechanism of activation by α-thrombin.—J. clin. Invest.64, 761, 1979.

    Article  PubMed  CAS  Google Scholar 

  23. Kisiel W., Canfield W. M., Ericsson L. H., Davie E. W.: Anticoagulant properties of bovine plasma protein C following activation by thrombin.—Biochemistry16, 5824, 1977.

    Article  PubMed  CAS  Google Scholar 

  24. Kisiel W., Ericsson L. H., Davie E. W.: Proteolytic activation of protein C from bovine plasma.—Biochemistry15, 4893, 1976.

    Article  PubMed  CAS  Google Scholar 

  25. Langendorff O.: Untersuchungen am überlebenden Säugetierherzen.—Pflügers Arch. ges. Physiol.66, 355, 1897.

    Article  Google Scholar 

  26. Mammen E. F., Thomas W. R., Seecer W. H.: Activation of purified prothrombin to autoprothrombin I or autoprothrombin II (piatelet cofactor III) or autoprothrombin H-A. Thrombos Diathes. haemorrh. (Stuttg.)5, 218, 1960.

    CAS  Google Scholar 

  27. Mannucci P. M., Viganò S.: Deficiencies of protein C, an inhibitor of blood coagulation. Lancetii, 463, 1982.

    Article  Google Scholar 

  28. Marciniak E.: Inhibitor of human blood coagulation elicited by thrombin.—J. Lab. clin. Med.79, 924, 1972.

    PubMed  CAS  Google Scholar 

  29. Marlar R. A., Griffin J. H.: Deficiency of protein C inhibitor in combined factor V/VIII deficiency disease.—J. clin. Invest.66, 1186, 1980.

    Article  PubMed  CAS  Google Scholar 

  30. Marlar R. A., Kleiss A. J., Griffin J. H.: Mechanism of action of human activated protein C, a thrombin-dependent anticoagulant enzyme.—Blood59, 1067, 1982.

    PubMed  CAS  Google Scholar 

  31. Miletich J. P., Kane W. H., Hofmann S. L., Stanford N., Majerus P. W.: Deficiency of factor X-factor V binding sites on the platelets of a patient with a bleeding disorder.—Blood.54, 1015, 1979.

    PubMed  CAS  Google Scholar 

  32. Murano G., Seegers W. H., Zolton R. P.: Autoprothrombin H-A: a competitive inhibitor of autoprothrombin C (factor Xa). A review with additions.—Thrombos. Diathes. haemorrh. (Stuttg.)57, 305, 1974.

    CAS  Google Scholar 

  33. Nesheim M. E., Taswell J. B., Mann K. G.: The contribution of bovine factor V and factor Va to the activity of prothrombinase.—J. biol. Chem.254, 10952, 1979.

    PubMed  CAS  Google Scholar 

  34. Nixon R. R., Comp P. C., Esmon C. T.: Role of Gla-domain in activated protein C.—Fed. Proc.42, 1993 # 1379, 1983. (Abstract).

    Google Scholar 

  35. Owen W. G., Esmon C. T.: Functional properties of an endothelial cell cofactor for thrombincatalyzed activation of protein C.—J. biol. Chem.256, 5532, 1981.

    PubMed  CAS  Google Scholar 

  36. Rapaport S. I., Schiffman S., Pathch M. J., Ames S. B.: The importance of activation of antihemophilic globulin and proaccelerin by traces of thrombin in the generation of intrinsic prothrombinase activity.—Blood21, 221, 1963.

    PubMed  CAS  Google Scholar 

  37. Salem H., Broze G., Miletich J., Majerus P.: Human coagulation factor Va is a cofactor for the activation of protein C.—Proc. nat. Acad. Sci. (Wash.)80, 1584, 1983.

    Article  CAS  Google Scholar 

  38. Stenflo J., Fernlund P.: Amino acid sequence of the heavy chain of bovine protein C. —J. biol. Chem.257, 12180, 1982.

    PubMed  CAS  Google Scholar 

  39. Suzuki K., Nishioka J., Hashimoto S.: Protein C inhibition. Purification from human plasma and characterization.—J. biol. Chem.258, 163, 1983.

    PubMed  CAS  Google Scholar 

  40. Tollefsen D. M., Feacler J. R., Majerus P. W.: The binding of thrombin to the surface of human platelets.—J. biol. Chem.249, 2646, 1974.

    PubMed  CAS  Google Scholar 

  41. Vehar G. A., Davie E. W.: Preparation and properties of bovine factor VIII.—Biochemistry19, 401, 1980.

    Article  PubMed  CAS  Google Scholar 

  42. Walker F. J.: Regulation of activated protein C by a new protein: a possible function for bovine protein S.—J. biol. Chem.255, 5521, 1980.

    PubMed  CAS  Google Scholar 

  43. Walker F. J.: Regulation of activated protein C by protein S: the role of phospholipid in factor Va inactivation.—J. biol. Chem.256, 11128, 1981.

    PubMed  CAS  Google Scholar 

  44. Walker F. J.: Regulation of bovine-activated protein C by protein S: the role of the cofactor protein in species specificity.—Thrombos. Res.22, 321, 1981.

    Article  CAS  Google Scholar 

  45. Wallace W. C., Bensusan H. B.: Protein phosphorylation in platelets stimulated by immobilized thrombin at 37 and 4°C—J. biol. Chem.255, 1932, 1980.

    PubMed  CAS  Google Scholar 

  46. Wetmore R., Gurewich V.: The role of fibrin monomer and anin vivo thrombin-induced anticoagulant in experimental venous thrombosis.—Scand. J. Haematol.12, 204, 1974.

    PubMed  CAS  Google Scholar 

  47. Zolton R. P., Seegers W. H.: Autoprothrombin II-A: thrombin removal and mechanism of induction of fibrinolysis.—Thrombos. Res.3, 23, 1973.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Thrombosis and Hematology, Oklohoma Medical Research Foundation, 825 N.E. 13th Street, 73104, Oklahoma City, Okla., USA

    Charles T. Esmon, Roger C. Carroll & Naomi L. Esmon

  2. Department of Pathology, at the Oklahoma University Health Sciences Center, Oklahoma City, Okia.

    Charles T. Esmon & Lawrence DeBault

  3. Department of Biochemistry, at the Cklahoma University Health Sciences Center, Oklahoma City, Okla.

    Charles T. Esmon & Roger C. Carroll

  4. Department of Physiology and Biophysics, at the Oklahoma University Health Sciences Center, Oklahoma City, Okla.

    Roger C. Carroll

  5. Department of Pathology Medicine, at the Oklahoma University Health Sciences Center, Oklahoma City, Okla.

    Philip C. Comp

Authors
  1. Charles T. Esmon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lawrence DeBault
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Roger C. Carroll
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Philip C. Comp
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Naomi L. Esmon
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This research was supported by the National Institutes of Health grant numbers: 1 R01 HL30340 (CTE) and R01 HL30411 (LD). This work was done during the tenure of an Established Investigatorship of the American Heart Association with funds contributed in part by the Oklahoma Affiliate (CTE) American Heart Association. Oklahoma Affiliate grant-in-aid no. G 82-54 (RCC).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Esmon, C.T., DeBault, L., Carroll, R.C. et al. Biochemical and physiological aspects of protein C. La Ricerca Clin. Lab. 14, 455–468 (1984). https://doi.org/10.1007/BF02904872

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02904872

Key words

Search

Navigation